Carcinoid syndrome natural history, complications and prognosis: Difference between revisions
| Line 18: | Line 18: | ||
*[[Obstruction|Bowel obstruction]] | *[[Obstruction|Bowel obstruction]] | ||
*[[Gastrointestinal bleeding]] | *[[Gastrointestinal bleeding]] | ||
* | *Carcinoid heart disease develops in more than one-third of patients with carcinoid syndrome:<ref> General Information About Gastrointestinal (GI) Carcinoid Tumors | ||
. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq#link/_49_toc Accessed on September 24, 2015</ref> | |||
*Fibrosis of the tricuspid valve and pulmonary valve, rarely the mitral valve in cases with left sided involvement | *Fibrosis of the tricuspid valve and pulmonary valve, rarely the mitral valve in cases with left sided involvement | ||
**"TIPS" - [[tricuspid insufficiency|Tricuspid Insufficiency]], [[pulmonary stenosis|Pulmonic Stenosis]] | :*Tricuspid and pulmonic regurgitation | ||
:*Pulmonary stenosis | |||
:*Mitral and aortic insufficiency | |||
:*Cardiac dysrhythmias | |||
**"TIPS" - [[tricuspid insufficiency|Tricuspid Insufficiency]], [[pulmonary stenosis|Pulmonic Stenosis]] | |||
==Prognosis== | ==Prognosis== | ||
Revision as of 00:28, 4 October 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome natural history, complications and prognosis |
|
FDA on Carcinoid syndrome natural history, complications and prognosis |
|
CDC on Carcinoid syndrome natural history, complications and prognosis |
|
Carcinoid syndrome natural history, complications and prognosis in the news |
|
Blogs on Carcinoid syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
If left untreated, patients with carcinoid syndrome may progress to develop flushing, diarrhea, and carcinoid heart disease (valvular heart disease and cardiac dysrythmias). Common complications of carcinoid tumor include increased risk of falls and injury (from hypotension), bowel obstruction, gastrointestinal bleeding, right-sided heart failure, and fibrosis of the tricuspid valve and pulmonary valve, and rarely the mitral valve in cases with left sided involvement. Prognosis is generally good and the 5-year survival rate of patients with carcinoid syndrome is approximately 69.7%.[1]
Natural History
- If left untreated, patients with carcinoid syndrome may progress to develop flushing, diarrhea, and carcinoid heart disease (valvular heart disease and cardiac dysrythmias):[2]
- Pathologically, the cardiac valves become thickened because of fibrosis
- Tricuspid and pulmonic valves are affected to a greater extent than the mitral and aortic valves
- They have a very slow growth rate compared to most malignant tumors
Complications
Common complications of carcinoid tumor include:[3]
- Increased risk of falls and injury (from hypotension)
- Bowel obstruction
- Gastrointestinal bleeding
- Carcinoid heart disease develops in more than one-third of patients with carcinoid syndrome:[4]
- Fibrosis of the tricuspid valve and pulmonary valve, rarely the mitral valve in cases with left sided involvement
- Tricuspid and pulmonic regurgitation
- Pulmonary stenosis
- Mitral and aortic insufficiency
- Cardiac dysrhythmias
- "TIPS" - Tricuspid Insufficiency, Pulmonic Stenosis
Prognosis
- Prognosis of carcinoid tumor is generally good and the 5-year survival rate of patients is approximately:[1]
- Stomach-75.1%
- Small Intestine-76.1%
- Appendix-76.3%
- Rectum-87.5%
- Factors that determine the prognosis of patients with gastrointestinal carcinoid tumors include:[5]
- Site of origin
- Size of the primary tumor
- Anatomical extent of disease
- Negative prognostic factors include:
- Carcinoid heart disease
- High concentrations of the tumor markers - urinary 5-HIAA and plasma chromogranin A
- Metastasis to the liver
- Carcinoid tumor in the thymus
- Overexpression of the proliferation antigen Ki-67
- Mutation in the p53 gene
References
- ↑ 1.0 1.1 Maggard MA, O'Connell JB, Ko CY (2004). "Updated population-based review of carcinoid tumors". Ann Surg. 240 (1): 117–22. PMC 1356383. PMID 15213627.
- ↑ General Information About Gastrointestinal (GI) Carcinoid Tumors . National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq#link/_49_toc Accessed on September 24, 2015
- ↑ Carcinoid syndrome. U.S. National Library of Medicine. https://www.nlm.nih.gov/medlineplus/ency/article/000347.htm
- ↑ General Information About Gastrointestinal (GI) Carcinoid Tumors . National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq#link/_49_toc Accessed on September 24, 2015
- ↑ Carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq